Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine and Isoniazid Interaction with Dolutegravir and Darunavir/Cobicistat
NCT02771249Phase 1Completed
- Sponsor
- National Institutes of Health
- Start
- Jun 2016
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rifapentine and isoniazid in Tuberculosis (TB), sponsored by National Institutes of Health. Started Jun 2016; status: completed.
02
Drugs
rifapentineisoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02771249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771249.